Can LDL cholesterol underestimate atherogenic particle number when LDL particle number is elevated?

The claim is well supported: LDL-C measures cholesterol mass, not the number of LDL particles. Thus, a person can have an optimal LDL-C yet a high concentration of atherogenic apoB-containing particles if each particle carries relatively little cholesterol.

Clinical and measurement implications

• LDL-C/LDL-P discordance means the cholesterol mass is distributed across more particles, implying lower average cholesterol content per LDL particle. This is the expected relationship when LDL-P is elevated despite optimal LDL-C.
• In the MESA cohort, among discordant individuals, cardiovascular risk and carotid intima–media thickness tracked more closely with LDL-P than with LDL-C. Those with low LDL-C but higher LDL-P had incident cardiovascular event rates of 11.3 versus 6.2 per 1,000 person-years compared with those with the opposite discordance.
• A systematic review found apoB to be more predictive than LDL-C in all nine reported head-to-head comparisons. Because major atherogenic particles carry one apoB molecule, apoB provides a practical estimate of total atherogenic particle burden.

Mechanistic context

• Higher triglycerides and metabolic traits promote lipid exchange and remodeling of apoB-containing lipoproteins, tending to produce smaller, relatively cholesterol-poor LDL particles. In Framingham, LDL-C relative to LDL-P declined as triglycerides increased.
• Particle size contributes to this pattern but does not completely determine it: cholesterol content can vary independently of size and triglyceride level. Nor is it established that cholesterol-poor LDL is inherently more harmful per particle; the clinically relevant issue is the higher particle number.

Clinical implications

• Discordance is especially relevant with diabetes, obesity, metabolic syndrome, or hypertriglyceridemia. In such settings, apoB or LDL-P can refine risk assessment when LDL-C appears reassuring.
• Bottom line: Optimal LDL-C does not always mean low atherogenic particle burden. Elevated LDL-P or apoB indicates more circulating atherogenic particles because each carries less cholesterol on average.